Sarah Phillips is an associate in the Mergers and Acquisitions Practice Group, and is resident in White & Case's Silicon Valley office.
Ms. Phillips advises corporate clients in connection with domestic and global mergers and acquisitions, venture capital and private equity transactions, divestitures, restructurings, and joint ventures in a broad range of industries, including healthcare, transportation and banking, but with a particular focus on the technology industry. Such technologies have included semiconductors, cloud computing and software, autonomous vehicles and blockchain.
Ms. Phillips also provides general corporate and corporate governance advice.
Representative matters include:
- Representation of Flying Eagle Acquisition Corp. (NYSE: FEAC), a SPAC, in its US$4.3 billion business combination with Skillz Inc., a mobile-gaming company based in California.
- Representation of Ascendant Digital Acquisition Corp. (NYSE: ACND), a SPAC, in its US$3 billion business combination with Beacon Street Group, LLC, a leading multi-brand digital subscription service platform that provides premium financial research, software, education and tools for self-directed investors.
- Representation of CM Life Sciences II (NASDAQ: CMII), a SPAC sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, in its US$1.23 billion business combination with SomaLogic, Inc., a protein biomarker discovery and clinical diagnostics company.
- Representation of FS Development Corp. II (NASDAQ: FSII), a SPAC, in its US$276.2 million business combination with Pardes Biosciences, Inc., an early stage biopharmaceutical company developing a potential direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections.
- Representation of QH Oil Investments LP, an affiliate of Qatar Investment Authority, on its investment in the US$230 million Series B fundraising of Tessera Therapeutics, Inc., an early-stage life sciences company founded by Flagship Pioneering that is pioneering Gene Writing, which was co-led by Alaska Permanent Fund Corporation, Altitude Life Science Ventures, and SoftBank Vision Fund 2.
- Representation of CVC Capital Partners in its acquisition of a majority stake in MedRisk, a leading provider of managed physical medicine services for the workers' compensation industry in the United States.